 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/13/2026 |
$14.90 |
$15.71 |
$14.76 |
$15.39 |
324.30K | | 01/14/2026 |
$15.47 |
$15.65 |
$14.25 |
$14.98 |
254.70K | | 01/15/2026 |
$14.92 |
$15.44 |
$14.69 |
$15.35 |
158.00K | | 01/16/2026 |
$15.50 |
$15.50 |
$14.88 |
$15.37 |
137.60K | | 01/20/2026 |
$15.00 |
$16.50 |
$15.00 |
$15.52 |
279.80K |
|
|
| Aardvark Therapeutics is a clinical-stage biopharmaceutical focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for treating metabolic diseases. Co. focused on developing Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Initial compounds target TAS2Rs expressed in the gut lumen, which normally respond to the nutrients in food and participate in the gut-brain axis. Co. lead product candidate, ARD-101 (denatonium acetate monohydrate), is an oral gut-restricted small-molecule agonist of certain TAS2Rs for which Co. initiated a Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome (PWS). | |
|
Aardvark Therapeutics (AARD) has the following price history information. Looking back at AARD historical stock prices for the last five trading days, on January 13, 2026, AARD opened at $14.90, traded as high as $15.71 and as low as $14.76, and closed at $15.39. Trading volume was a total of 324.30K shares. On January 14, 2026, AARD opened at $15.47, traded as high as $15.65 and as low as $14.25, and closed at $14.98. Trading volume was a total of 254.70K shares. On January 15, 2026, AARD opened at $14.92, traded as high as $15.44 and as low as $14.69, and closed at $15.35. Trading volume was a total of 158.00K shares. On January 16, 2026, AARD opened at $15.50, traded as high as $15.50 and as low as $14.88, and closed at $15.37. Trading volume was a total of 137.60K shares. On January 20, 2026, AARD opened at $15.00, traded as high as $16.50 and as low as $15.00, and closed at $15.52. Trading volume was a total of 279.80K shares.
AARD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aardvark Therapeutics shares, starting with a $10,000 purchase of AARD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/14/2025 |
|
| End date: |
01/20/2026 |
|
| Start price/share: |
$13.30 |
|
| End price/share: |
$15.52 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
16.69% |
|
| Annualized Gain: |
17.92% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,669.00 |
|
| Years: |
0.93 |
|
|
|
| Date |
Close |
| 01/13/2026 | $15.39 | | 01/14/2026 | $14.98 | | 01/15/2026 | $15.35 | | 01/16/2026 | $15.37 | | 01/20/2026 | $15.52 |
|
|
Free AARD Email Alerts:
